Hepatitis C lipo-Viro-particle from chronically infected patients interferes with TLR4 signaling in dendritic cell.

by Sophie Agaugué, Laure Perrin-Cocon, Patrice André, Vincent Lotteau
Published 2007-01-01

442 ICT01, an anti-BTN3A mAb that activates Vg9Vd2 T cells, plus interleukin-2: a potent and promising combination for cancer immunotherapy

by Jennifer Sims, Patrick Brune, René Hoet, Emmanuel Valentin, LE Suong, Sophie Agaugué, Paul Frohna
Published 2020-11-01

687 Enhancement of anti-tumor immunity by ICT01: a novel g9d2 T cell-activating antibody targeting butyrophilin-3A (BTN3A)

by Jennifer Sims, Patrick Brune, René Hoet, Emmanuel Valentin, LE Suong, Sophie Agaugué, Remy Castellano, Alem Truneh
Published 2020-11-01

Th1 disabled function in response to TLR4 stimulation of monocyte-derived DC from patients chronically-infected by hepatitis C virus.

by Laure Perrin-Cocon, Sophie Agaugué, Olivier Diaz, Béatrice Vanbervliet, Sandra Dollet, Aurélie Guironnet-Paquet, Patrice André, Vincent Lotteau
Published 2008-01-01

Overcoming Target Driven Fratricide for T Cell Therapy

by Eytan Breman, Benjamin Demoulin, Sophie Agaugué, Sebastien Mauën, Alexandre Michaux, Lorraine Springuel, Julien Houssa, Fanny Huberty, Céline Jacques-Hespel, Céline Marchand, Jérôme Marijsse, Thuy Nguyen, Nancy Ramelot, Benjamin Violle, Dorothée Daro, Peter De Waele, David E. Gilham, Valérie Steenwinckel
Published 2018-12-01